Home›Companies›Biotech & Pharma›Novastream Therapeutics

Novastream Therapeutics Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 17, 2023·Suggest an edit

About Novastream Therapeutics

Novastream Therapeutics is a private company based in Denver, Colorado, incorporated in 2021 in Delaware. It has reported $50,000 raised in one offering on Form D since October 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 3, 2023Oct 17, 2023$50,000of $250K target4$12,500Securities on exercise, SAFERule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Novastream Therapeutics's Form D filed Oct 17, 2023.

MO
Manuel Ornelas
President and director
MW
Mark Webb
Director
JN
Jason Novak
Director
TK
Thomas Kluz
Director

Sources

  1. SECNovastream Therapeutics Inc. filing history